[引用][C] An 11 β-hydroxylase inhibitor in the treatment of resistant ascites

S Shaldon, JR Mclaren - The Lancet, 1960 - Elsevier
Discussion The presence of an insulin-secreting tumour cannot be excluded because
hypoglycxmia is precipitated when I-leucine is given by mouth. Schwartz et al.(1958) …
被引用次数：24 相关文章

[引用][C] AN 11 β-HYDROXYLASE INHIBITOR IN THE TREATMENT OF RESISTANT ASCITES

S Shaldon, JR Mclaren - The Lancet, 1960 - thelancet.com

[引用][C] An 11beta-hydroxylase inhibitor in the treatment of resistant ascites

S SHALDON, JR McLAREN - Lancet (London, England), 1960 - pubmed.ncbi.nlm.nih.gov

[引用][C] An 11beta-hydroxylase inhibitor in the treatment of resistant ascites.

S SHALDON, JR McLAREN - Lancet (London, England), 1960 - europepmc.org
An 11beta-hydroxylase inhibitor in the treatment of resistant ascites. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …